Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: Evaluation of their impact on skin barrier function
Acta Pharmaceutica · 2024
DOI: 10.2478/acph-2024-0014 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Pharmaceutica, 2024. Verfasst von Mercedes Vitek und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana Slovenia. Hauptthemen laut MEDLINE: Liquid Crystals, Administration, Cutaneous, Skin, Dermatitis, Atopic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The principal function of skin is to form an effective barrier between the human body and its environment. Impaired barrier function represents a precondition for the development of skin diseases such as atopic dermatitis (AD), which is the most common inflammatory skin disease characterized by skin barrier dysfunction. AD significantly affects patients’ quality of life, thus, there is a growing interest in the development of novel delivery systems that would improve therapeutic outcomes. Herein, eight novel lyotropic liquid crystals (LCCs) were investigated for the first time in a double-blind, interventional, before-after, single-group trial with healthy adult subjects and a twice-daily application regimen. LCCs consisted of constituents with skin regenerative properties and exhibited lamellar micro-structure, especially suitable for dermal application. The short- and long-term effects of LCCs on TEWL, SC hydration, erythema index, melanin index, and tolerability were determined and compared with baseline. LCCs with the highest oil content and lecithin/Tween 80 mixture stood out by providing a remarkable 2-fold reduction in TEWL values and showing the most distinctive decrease in skin erythema levels in both the short- and long-term exposure. Therefore, they exhibit great potential for clinical use as novel delivery systems for AD treatment, capable of repairing skin barrier function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1University of Ljubljana Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana Slovenia.
Zitieren
APA
Vitek, M., & Matjaž, M. G. (2024). Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: Evaluation of their impact on skin barrier function. Acta Pharmaceutica. https://doi.org/10.2478/acph-2024-0014
Vancouver
Vitek M, Matjaž MG. Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: Evaluation of their impact on skin barrier function. Acta Pharmaceutica. 2024. doi:10.2478/acph-2024-0014
BibTeX
@article{Vitek2024,
author = {Vitek, Mercedes and Matjaž, Mirjam Gosenca},
title = {Clinical application of hempseed or flaxseed oil-based lyotropic liquid crystals: Evaluation of their impact on skin barrier function},
journal = {Acta Pharmaceutica},
year = {2024},
doi = {10.2478/acph-2024-0014}
}
EUVIMED